Impact of EGFR expression on colorectal cancer patient prognosis and survival von Spano, J.-P., Lagorce, C., Atlan, D., Milano, G., Domont, J., Benamouzig, R., Attar, A., Benichou, J., Martin, A., Morere, J.-F., Raphael, M., Penault-Llorca, F., Breau, J.-L., Fagard, R., Khayat, D., Wind, P.

Volltext

Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature von Des Guetz, G, Uzzan, B, Nicolas, P, Cucherat, M, Morere, J-F, Benamouzig, R, Breau, J-L, Perret, G-Y

Volltext

Indicators of non-uptake of breast cancer screening: Results from the EDIFICE 6 survey von Morere, J.-F., Viguier, J., Greillier, L., Roupret, M., Touboul, C., Lhomel, C., Couraud, S., de La Motte Rouge, T., Eisinger, F.

Volltext

Microsatellite Instability and Sensitivitiy to FOLFOX Treatment in Metastatic Colorectal Cancer von DES GUETZ, G, MARIANI, P, BREAU, J.-L, FAGARD, R, SCHISCHMANOFF, P. O, CUCHEROUSSET, J, BENAMOUN, M, LAGORCE, C, SASTRE, X, LE TOUMELIN, P, UZZAN, B, PERRET, G.-Y, MORERE, J.-F

Volltext

Prostate cancer screening: contrasting trends von Eisinger, F., Morère, J. F., Touboul, C., Pivot, X., Coscas, Y., Blay, J. Y., Lhomel, C., Viguier, J.

Volltext

Prognostic Impact of Microsatellite Instability in Colorectal Cancer Patients Treated with Adjuvant FOLFOX von DES GUETZ, G, LECAILLE, C, SCHISCHMANOFF, P. O, MORERE, J. F, MARIANI, P, BENNAMOUN, M, UZZAN, B, NICOLAS, P, BOISSEAU, A, SASTRE, X, CUCHEROUSSET, J, LAGORCE, C

Volltext

Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma von Spano, J-P, Soria, J-C, Kambouchner, M, Piperno-Neuman, S, Morin, F, Morere, J-F, Martin, A, Breau, J-L

Volltext

Colorectal liver metastases are more often super wild type. Toward treatment based on metastatic site genotyping? von Allard, M. A., Saffroy, R., de la Maisonneuve, P. Bouvet, Ricca, L., Bosselut, N., Hamelin, J., Lecorche, E., Bejarano, M. A., Innominato, P., Sebagh, M., Adam, R., Morère, J. F., Lemoine, A.

Volltext

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer von Fumoleau, P., Largillier, R., Clippe, C., Dièras, V., Orfeuvre, H., Lesimple, T., Culine, S., Audhuy, B., Serin, D., Curé, H., Vuillemin, E., Morère, J.-F., Montestruc, F., Mouri, Z., Namer, M.

Volltext

Oncology in 2012: from personalized medicine to precision medicine von Morere, J. F.

Volltext

168P Real life practice of gefitinib in patients (pts) with non-small-cell lung cancer (NSCLC) depending on epidermal growth factor receptor (EGFR) mutation status: Results from th... von Cadranel, J., Brambilla, E., Morere, J.F., Rondeau, V., Fabre, E., Lemaire, B., Monnet, I., Licour, M., Perol, M.

Volltext

ESMO 2014: new trends in precision medicine von Morere, J. F., Innominato, P.

Volltext

Prostate cancer screening in France: Results from the EDIFICE surveys von Morère, J-F, Touboul, C, Lhomel, C, Rouprêt, M

Volltext

Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin von Pujol, J.-L., Breton, J.-L., Gervais, R., Rebattu, P., Depierre, A., Morère, J.-F., Milleron, B., Debieuvre, D., Castéra, D., Souquet, P.-J., Moro-Sibilot, D., Lemarié, E., Kessler, R., Janicot, H., Braun, D., Spaeth, D., Quantin, X., Clary, C.

Volltext

Identification of a functional EGF-R/p60c-src/STAT3 pathway in colorectal carcinoma: analysis of its long-term prognostic value von Hbibi, A Tadlaoui, Lagorce, C, Wind, P, Spano, J P, Des Guetz, G, Milano, G, Benamouzig, R, Rixe, O, Morere, J-F, Breau, J-L, Martin, A, Fagard, R

Volltext

Melanoma risk-takers: fathers and sons von Eisinger, F., Morère, J.-F., Pivot, X., Grange, F., Lhomel, C., Mortier, L., Robert, C., Saiag, P., Sassolas, B., Viguier, J.

Volltext

Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC von Socinski, Mark A, Jotte, Robert M, Cappuzzo, Federico, Orlandi, Francisco, Stroyakovskiy, Daniil, Nogami, Naoyuki, Rodríguez-Abreu, Delvys, Moro-Sibilot, Denis, Thomas, Christian A, Barlesi, Fabrice, Finley, Gene, Kelsch, Claudia, Lee, Anthony, Coleman, Shelley, Deng, Yu, Shen, Yijing, Kowanetz, Marcin, Lopez-Chavez, Ariel, Sandler, Alan, Reck, Martin

Volltext

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer von Solomon, Benjamin J, Mok, Tony, Kim, Dong-Wan, Wu, Yi-Long, Nakagawa, Kazuhiko, Mekhail, Tarek, Felip, Enriqueta, Cappuzzo, Federico, Paolini, Jolanda, Usari, Tiziana, Iyer, Shrividya, Reisman, Arlene, Wilner, Keith D, Tursi, Jennifer, Blackhall, Fiona

Volltext

Prise en charge des effets dermatologiques sous erlotinib. Résultats de l’étude PRECEDE von Janus, N., Launay-Vacher, V., Robert, C., Souquet, P.-J., Mateus, C., Dreno, B., Deray, G., Morere, J.-F., Deplanque, G.

Volltext

Anaphylaxis after oxaliplatin von Médioni, J., Coulon, M. A., Morere, J. F., Hennebelle, F., Piperno-Neumann, S., Breau, J. L.

Volltext